These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 7523555

  • 1. Selective alpha IIb beta 3 receptor blockage with peptide TP9201 prevents platelet uptake on Dacron vascular grafts without significant effect on bleeding time.
    Mazur C, Tschopp JF, Faliakou EC, Gould KE, Diehl JT, Pierschbacher MD, Connolly RJ.
    J Lab Clin Med; 1994 Oct; 124(4):589-99. PubMed ID: 7523555
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Inhibition of coronary artery reocclusion after thrombolysis with an RGD-containing peptide with no significant effect on bleeding time.
    Tschopp JF, Driscoll EM, Mu DX, Black SC, Pierschbacher MD, Lucchesi BR.
    Coron Artery Dis; 1993 Sep; 4(9):809-17. PubMed ID: 8287215
    [Abstract] [Full Text] [Related]

  • 4. In vivo inhibition of acute platelet-dependent thrombosis in a baboon model by Bay U3405, a thromboxane A2-receptor antagonist.
    Kotzé HF, Lamprecht S, Badenhorst PN, van Wyk V, Roodt JP, Alexander K.
    Thromb Haemost; 1993 Oct 18; 70(4):672-5. PubMed ID: 8115994
    [Abstract] [Full Text] [Related]

  • 5. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
    Ramjit DR, Lynch JJ, Sitko GR, Mellott MJ, Holahan MA, Stabilito II, Stranieri MT, Zhang G, Lynch RJ, Manno PD.
    J Pharmacol Exp Ther; 1993 Sep 18; 266(3):1501-11. PubMed ID: 8371153
    [Abstract] [Full Text] [Related]

  • 6. Effect of a synthetic peptide corresponding to residues 313 to 320 of the alphaIIb subunit of the human platelet integrin alphaIIbbeta3 on carotid artery thrombosis in rabbits.
    Papamichael ND, Stathopoulou EM, Roussa VD, Tsironis LD, Kotsia AP, Stanica RM, Moussis V, Tsikaris V, Katsouras CS, Tselepis AD, Michalis LK.
    J Pharmacol Exp Ther; 2009 May 18; 329(2):634-40. PubMed ID: 19244095
    [Abstract] [Full Text] [Related]

  • 7. Antiplatelet and antithrombotic effects of YM337, the Fab fragment of a humanized anti-GPIIb/IIIa monoclonal antibody in monkeys.
    Kaku S, Kawasaki T, Hisamichi N, Sakai Y, Taniuchi Y, Inagaki O, Yano S, Suzuki K, Terazaki C, Masuho Y, Satoh N, Takenaka T, Yanagi K, Ohshima N.
    Thromb Haemost; 1996 Apr 18; 75(4):679-84. PubMed ID: 8743199
    [Abstract] [Full Text] [Related]

  • 8. Identification of low molecular weight GP IIb/IIIa antagonists that bind preferentially to activated platelets.
    Bednar RA, Gaul SL, Hamill TG, Egbertson MS, Shafer JA, Hartman GD, Gould RJ, Bednar B.
    J Pharmacol Exp Ther; 1998 Jun 18; 285(3):1317-26. PubMed ID: 9618439
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Nonpeptide glycoprotein IIb/IIIa inhibitors. 15. Antithrombotic efficacy of L-738,167, a long-acting GPIIb/IIIa antagonist, correlates with inhibition of adenosine diphosphate-induced platelet aggregation but not with bleeding time prolongation.
    Cook JJ, Sitko GR, Holahan MA, Stranieri MT, Glass JD, Askew BC, McIntyre CJ, Claremon DA, Baldwin JJ, Hartman GD, Gould RJ, Lynch JJ.
    J Pharmacol Exp Ther; 1997 May 18; 281(2):677-89. PubMed ID: 9152373
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of thrombosis by a selective fibrinogen receptor antagonist without effect on bleeding time.
    Tschopp JF, Mazur C, Gould K, Connolly R, Pierschbacher MD.
    Thromb Haemost; 1994 Jul 18; 72(1):119-24. PubMed ID: 7974359
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The systemic activation of platelets by Dacron grafts.
    Shoenfeld NA, Connolly R, Ramberg K, Valeri CR, Eldrup-Jorgensen J, Callow AD.
    Surg Gynecol Obstet; 1988 May 18; 166(5):454-7. PubMed ID: 2966442
    [Abstract] [Full Text] [Related]

  • 14. New RGD analogue inhibits human platelet adhesion and aggregation and eliminates platelet deposition on canine vascular grafts.
    Rubin BG, McGraw DJ, Sicard GA, Santoro SA.
    J Vasc Surg; 1992 Apr 18; 15(4):683-91; discussion 691-2. PubMed ID: 1560559
    [Abstract] [Full Text] [Related]

  • 15. Ex vivo and in vitro platelet adhesion on RFGD deposited polymers.
    Kiaei D, Hoffman AS, Hanson SR.
    J Biomed Mater Res; 1992 Mar 18; 26(3):357-72. PubMed ID: 1613026
    [Abstract] [Full Text] [Related]

  • 16. Non-peptide GPIIb/IIIa inhibitors. 20. Centrally constrained thienothiophene alpha-sulfonamides are potent, long acting in vivo inhibitors of platelet aggregation.
    Egbertson MS, Cook JJ, Bednar B, Prugh JD, Bednar RA, Gaul SL, Gould RJ, Hartman GD, Homnick CF, Holahan MA, Libby LA, Lynch JJ, Lynch RJ, Sitko GR, Stranieri MT, Vassallo LM.
    J Med Chem; 1999 Jul 01; 42(13):2409-21. PubMed ID: 10395482
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.